At a glance
ClinicalIndex Comparison Record- ✓Presence of a long bone fracture (humerus, femur, or tibia)
- ✓Age ≥18 years
- ✓Ability to follow-up at clinic for 12 months
- ✕Pathologic fractures (e.g., from tumor, cyst, or Paget's disease)
- ✕Open fractures of Gustilo-Anderson type IIIB or C
- ✕Multiple fractures
- ✕Presentation delay >2 weeks from time of injury
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Hypovitaminosis D and Vitamin D Supplementation on Fracture Nonunion Rates
In Brief
A clinical study evaluating Vitamin D and Placebo for Hypovitaminosis D. Completed, enrolled 113 participants across 1 site.
Detailed Summary
The purpose of the study is to determine whether vitamin D supplementation in patients with hypovitaminosis D can decrease nonunion (failure to heal) incidence in patients with fractures of the humerus, femur, or tibia. The central hypothesis of the study is that vitamin D supplementation in patients with fractures and hypovitaminosis D will decrease the risk of nonunion compared to placebo treatment.
Study Details
Timeline
Interventions
Patients that are Vitamin D deficient and randomized to the treatment group will receive a 10,000 IU dose of Vitamin D.
Patients that are Vitamin D deficient maybe randomized to the placebo group D.